18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

Clinical trial NCT06937112 · RECRUITING

Trial details

NCT number: NCT06937112
Sponsor: Nanjing First Hospital, Nanjing Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancers Pancreatic Cancer Neuroendocrine Tumors Thyroid Cancer

Start date: 2025-04-10
Primary completion: 2026-01-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.